Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.

Neuropsychopharmacology · 2017 · PMC5312066 · PMID 27681442

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Subjects experiencing baseline suicidal thoughts, assessed by MADRS item 10 score ⩾2, also showed a trend for a numerically superior response to lanicemine over placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.